Cell and gene therapy
（CGT，Cell and gene therapy）
It is a new field of cancer and genetic disease treatment, and it is also the most promising development direction in the field of biomedicine. Currently recognized in the industry, cell and gene therapy refers to the transfer of determined genetic material into specific target cells of a patient, and through gene addition, gene modification, gene silencing, etc., to modify the expression of individual genes or repair abnormal genes, so as to achieve the purpose of curing the disease. process.
Cell and gene therapy are inseparable from gene editing, and the development of therapeutic regimens and the evaluation of efficacy are inseparable from cell analysis tools. “Agilent Cell and Gene Therapy Webinar Series” focuses on CGT, the golden track, bringing together Agilent technical experts from multiple departments, covering gene editing, cell analysis, quality control, etc. We look forward to discussing hot topics in this field with our colleagues in basic scientific research, technology transformation, and production quality control of CGT.
April 27th, “Agilent Cell and Gene Therapy Webinar Series—Phase I Immunotherapy Research Road< /span>” Specially invited three product application experts from Agilent Diagnostics and Genomics Division and Cell Analysis Division to give you a detailed explanation of the application of CGT technology in the field of immunotherapy.
Course Introduction:
01< /p>
“Solutions for Design and Screening of Tumor Immune Cells”
Tumor Immunity Therapy is a hot research topic in the field of cancer treatment in recent years, and cell-based analysis plays a pivotal role. This course analyzes the research strategies in the field of tumor immunotherapy step by step from the cellular level, and leads you to appreciate the application of RTCA (Real-time Label-Free Analysis System) and NovoCyte flow cytometry, two powerful tools of cell analysis, in this field, so as to improve your data quality to accelerate your research progress.
02
GRNA Design-to-Synthesis Solutions
Agilent provides high-quality chemically synthesized gRNAs for cell and gene therapy. Our online design software can easily design and customize gRNAs.
03
Evaluation of Cell Therapy Using Seahorse Technology Potency
and Persistence”
Studies show that cellular metabolism can Regulates immune cell responses in health and disease states. Agilent’s Seahorse Cell Energy Metabolism Technology, an innovative technology for studying immune cell metabolism, provides unique insights into the key drivers behind immune cell function, enabling optimization of cell therapy products by regulating metabolic programs and improving metabolic fitness.
About AgilentAgilent Technologies, Inc. (New York Stock Exchange) :A) is a global leader in the life sciences, diagnostics and applied chemistry markets, dedicated to providing keen insight and innovative experiences to improve the quality of life. Agilent’s instruments, software, services, solutions and experts provide more reliable answers to customers’ most challenging challenges. In fiscal 2021, Agilent’s revenue was $6.32 billion and it employs approximately 17,000 people worldwide. Long press to identify the QR code and follow Agilent cell analysis